Key facts
- It has raised $150K; the latest was Seed Round ($150K) in Jan 2025.
- Notable investors include Plug and Play Tech Center, SVG Ventures|THRIVE, Front Row Ventures, Cultivator, AgWest — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for PathoScan
- ·The full record, as it builds
Funding rounds
No funding rounds for PathoScan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PathoScan
Developer of a portable agricultural disease testing device designed for rapid and on-site analysis of crops. The company's device utilizes a disposable cartridge system, bioluminescent assays, advanced DNA amplification, and artificial intelligence to detect crop diseases on-site to deliver test results within minutes, enabling farmers to make informed decisions about disease management and treatment application on time, potentially reducing crop loss, and improving overall yield.
- Sector
- Business Products and Services (B2B)
- HQ
- Saskatoon, Canada
- Founded
- 2022
- Employees
- 3
- Website
- pathoscan.com/
- Ownership
- Privately Held (backing)
PathoScan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PathoScan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PathoScan in its N-PORT filings yet. We sweep new filings monthly.